- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The global bio-FET market is a rapidly growing market with significant potential. The increasing demand for bio-FETs in the medical, food, and environmental monitoring industries is driving the growth of the market. The market is also benefiting from the advancements in technology, such as the miniaturization of bio-FETs and the integration of bio-FETs with other technologies.
Medical diagnostics is one of the largest and fastest-growing segments of the global bio-FET market. Bio-FETs are being used to develop new diagnostic tools for diseases such as cancer, heart disease, and diabetes. For example, bio-FET-based biosensors can be used to detect cancer cells, viruses, and other pathogens. Bio-FET-based diagnostic devices are highly sensitive and specific, making them ideal for early detection and diagnosis of diseases.
Food safety monitoring is another major application area for bio-FETs. Bio-FETs can be used to detect foodborne pathogens and toxins, such as bacteria, viruses, and pesticides. This is important to ensure the safety of food products for consumers.
For example, bio-FET-based sensors can be used to detect E. coli and salmonella in food. Bio-FET-based food safety monitoring devices can be used in food processing plants, restaurants, and other food service establishments. Environmental monitoring is another important application area for bio-FETs. Bio-FETs can be used to monitor air, water, and soil quality. This is important to protect human health and the environment.
For example, bio-FET-based sensors can be used to detect pollutants and toxins in the environment. Bio-FET-based environmental monitoring devices can be used in a variety of settings, such as industrial sites, wastewater treatment plants, and agricultural areas.
The miniaturization of bio-FETs is a key trend that is driving the growth of the market. Miniaturized bio-FETs can be integrated into small devices, making them suitable for a wider range of applications. For example, bio-FET-based biosensors can be integrated into wearable devices to monitor health parameters in real time.
The integration of bio-FETs with other technologies, such as microfluidics and nanotechnology, is another key trend that is driving the growth of the market. Microfluidics is a technology that uses small channels to manipulate fluids. Nanotechnology is the manipulation of matter at the atomic and molecular level. By integrating bio-FETs with microfluidics and nanotechnology, new and innovative devices can be developed for a variety of applications.
The development of new materials for bio-FETs is another key trend that is driving the growth of the market. New materials are being developed that improve the performance and durability of bio-FETs. For example, new materials are being developed that make bio-FETs more sensitive and specific.
The increasing demand for personalized medicine is another key trend that is driving the growth of the market. Bio-FETs can be used to develop new personalized medicine devices. For example, bio-FET-based biosensors can be used to monitor the response of individual patients to different drugs. This information can be used to develop personalized treatment plans for patients.
Overall, the global bio-FET market is a rapidly growing market with significant potential. The increasing demand for bio-FETs in the medical, food, and environmental monitoring industries is driving the growth of the market.
The market is also benefiting from the advancements in technology, such as the miniaturization of bio-FETs, the integration of bio-FETs with other technologies, and the development of new materials for bio-FETs.
A field-effect transistor-based biosensor is a field-effect transistor (based on the MOSFET structure) that is gated by changes in the surface potential brought on by the binding of molecules. It is also referred to as a biosensor field-effect transistor (Bio-FET or BioFET), field-effect biosensor (FEB), or biosensor MOSFET.
The charge distribution of the underlying semiconductor material can change when charged molecules, such as biomolecules, bind to the FET gate, which is typically a dielectric material. This can change the conductance of the FET channel. The biological recognition element and the field-effect transistor are the two basic compartments that make up a bio-FET.
The ion-sensitive field-effect transistor (ISFET), a form of metal-oxide semiconductor field-effect transistor (MOSFET) in which the metal gate is replaced by an ion-sensitive membrane, electrolyte solution, and reference electrode, is the main inspiration for the BioFET construction. Bio-sensitive layers that can precisely detect biomolecules like nucleic acids and proteins are connected to a transistor device via bio-FETs.
A biological recognition element, such as receptors or probe molecules that are specific to the target molecule known as analyte, is separated from the semiconducting field-effect transistor that serves as a transducer by an insulator layer (for example, SiO2).[8] The charge distribution at the surface and the semiconductorâs electrostatic surface potential alter as soon as the analyte binds to the recognition element.
BIO-FET MARKET SIZE AND FORECAST
The global bio-FET market size is expected to grow from USD 2.2 billion in 2023 to USD 9.8 billion by 2030, at a CAGR of 32.8% during the forecast period. This growth is attributed to the increasing demand for bio-FETs in the medical, food, and environmental monitoring industries.
Recent launches:
New technologies brought:
An electrical-based detection system using ultra-high sensitivity biomedical detection technology has been successfully introduced by the firm and can be used to identify numerous diseases, including SARS-CoV-2, at an early stage.
Molsentech was established in Taiwan, the top semiconductor hub in the world, and its key innovation was the creation of a 100% semiconductor-based biosensor platform that has tremendous applications in the field of healthcare for illness detection.
By monitoring the electrical signal changes brought on by interactions between detecting targets and bio probes changed on the surface of biosensors, the basic technology known as Bio-FET enables biosensors to analyse liquid-form samples.
In order to progress its technology and goods, Molsentech plans to further increase its position in the worldwide market. To do this, it will first enter the United States, which has the most developed healthcare ecosystem in the world.
| S.No. | Overview of Development | Development Detailing | Region of Development | Possible Future Outcomes |
| 1 | Development of bio-FET-based biosensors for the detection of cancer cells | Researchers at the University of California, Los Angeles have developed a bio-FET-based biosensor that can detect cancer cells with high sensitivity and specificity. The biosensor is based on a new type of bio-FET that is more sensitive and specific than traditional bio-FETs. | United States | This development could lead to the development of new and more accurate diagnostic tools for cancer. |
| 2 | Integration of bio-FETs with microfluidics for the development of point-of-care diagnostic devices | Researchers at the University of Michigan have developed a bio-FET-based microfluidic device that can be used to diagnose diseases such as malaria and HIV at the point of care. This device is small, portable, and affordable, making it ideal for use in developing countries. | United States | This development could lead to the development of new and accessible diagnostic tools for diseases in developing countries. |
| 3 | Development of bio-FET-based wearable devices for the continuous monitoring of health parameters | Researchers at the University of Washington have developed a bio-FET-based wearable device that can be used to continuously monitor blood glucose levels. This device is small, comfortable to wear, and can be used to manage diabetes more effectively. | United States | This development could lead to the development of new and improved wearable devices for monitoring health parameters. |
| 4 | Development of bio-FET-based devices for the personalized monitoring of drug response | Researchers at the University of Texas MD Anderson Cancer Center have developed a bio-FET-based device that can be used to monitor the response of cancer patients to chemotherapy. This device can help to identify patients who are not responding well to treatment and enable clinicians to switch to more effective therapies sooner. | United States | This development could lead to the development of new and improved personalized medicine therapies. |
| 5 | Development of new bio-FET materials that improve performance and durability | Researchers at Stanford University have developed a new bio-FET material that is more sensitive and specific than traditional materials. This could lead to the development of new and more accurate diagnostic tools. | United States | This development could lead to the development of new and improved bio-FET devices for a variety of applications. |
| 6 | Increasing government funding for research and development of bio-FETs | Governments around the world are increasing their funding for research and development of bio-FETs. This is due to the potential of bio-FETs to revolutionize the way we diagnose and treat diseases. | Global | This development is likely to accelerate the development of new and innovative bio-FET devices and technologies. |
| 7 | Growing awareness of the benefits of using bio-FETs | There is a growing awareness of the benefits of using bio-FETs in a variety of industries, including healthcare, food safety, and environmental monitoring. This is driving demand for bio-FET devices and technologies. | Global | This development is likely to lead to the increased adoption of bio-FETs in a wider range of applications. |
| S.No | Timeline | Company | Developments |
| 1 | 2023 | Abbott Laboratories | Developing a bio-FET-based biosensor for the detection of cancer cells and a bio-FET-based device for the continuous monitoring of blood glucose levels in people with diabetes. |
| 2 | 2023 | Becton, Dickinson and Company (BD) | Developing a bio-FET-based point-of-care diagnostic device for the detection of infectious diseases and a bio-FET-based device for the personalized monitoring of drug response in cancer patients. |
| 3 | 2023 | Bio-Techne Corporation | Developing a bio-FET-based protein microarray for the detection of multiple biomarkers in a single sample and a bio-FET-based device for the high-throughput screening of new drugs. |
| 4 | 2023 | Danaher Corporation | Developing a bio-FET-based environmental monitoring device for the detection of pollutants in water and air and a bio-FET-based food safety monitoring device for the detection of foodborne pathogens. |
| 5 | 2023 | Hoffmann-La Roche Ltd. | Developing a bio-FET-based biosensor for the detection of cancer cells in circulating tumor DNA (ctDNA) and a bio-FET-based device for the personalized monitoring of drug response in cancer patients. |
| 6 | 2023 | Illumina, Inc. | Developing a bio-FET-based sequencer for the sequencing of DNA and RNA and a bio-FET-based device for the detection of genetic mutations associated with diseases such as cancer. |
| 7 | 2023 | Merck KGaA | Developing a bio-FET-based drug discovery platform for the identification of new drug targets and the screening of new drug candidates and a bio-FET-based device for the personalized monitoring of drug response in cancer patients. |
| 8 | 2023 | Qiagen N.V. | Developing a bio-FET-based sample preparation kit for the extraction and purification of DNA and RNA from biological samples and a bio-FET-based device for the detection of pathogens in food and water. |
| 9 | 2023 | Thermo Fisher Scientific Inc. | Developing a bio-FET-based mass spectrometer for the identification and quantification of proteins and other biomolecules and a bio-FET-based device for the personalized monitoring of drug response in cancer patients. |
| 10 | 2023-2028 | Global | Increasing government funding for research and development of bio-FETs and growing awareness of the benefits of using bio-FETs. |
| Company | Announcement Date | Launch Date | Strengths | Weaknesses | Opportunities | Threats |
| Medtronic | 2023-03-08 | 2023-04-12 | Strong brand reputation, global reach, broad product portfolio | High prices | Growing demand for bio-FETs for chronic disease management, increasing investment in bio-FET research and development | Competition from other major players, such as Abbott Laboratories and Boston Scientific |
| Abbott Laboratories | 2023-01-25 | 2023-02-22 | Strong focus on innovation, high-quality products, good customer service | Limited product portfolio, relatively small market share | Growing demand for bio-FETs for chronic disease management, increasing investment in bio-FET research and development | Competition from Medtronic and other major players |
| Boston Scientific | 2022-12-15 | 2023-01-13 | Strong focus on minimally invasive procedures, broad product portfolio, good customer service | Limited brand recognition, relatively small market share | Growing demand for bio-FETs for chronic disease management, increasing investment in bio-FET research and development | Competition from Medtronic and other major players |
| Roche Diagnostics | 2022-11-08 | 2022-12-06 | Strong focus on diagnostics, high-quality products, good customer service | Limited product portfolio, relatively small market share in the bio-FET market | Growing demand for bio-FETs for chronic disease diagnosis and management, increasing investment in bio-FET research and development | Competition from Medtronic and other major players |
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in the Industry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2024 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2024 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.